BAL im Tierexperiment unter besonderer Berücksichtigung induzierender und therapeutischer Aspekte in der ARDS-Forschung

P.-G. Germann; D. Häfner; L. Wollin

doi:10.1055/s-2005-870924

Pneumologie, Table of Contents

Pneumologie 2005; 59(7): 499-501
DOI: 10.1055/s-2005-870924

Workshop

BAL im Tierexperiment unter besonderer Berücksichtigung induzierender und therapeutischer Aspekte in der ARDS-Forschung

P.-G. Germann¹ , D. Häfner² , L. Wollin²

¹Department of Toxicology and Pathology, Preclinical Safety, Novartis Pharma AG, Basel, Schweiz
²Department of Respiratory Pharmacology, Byk Gulden, Konstanz, Deutschland

Abstract

Full Text

References

Literatur

1 Häfner D, Germann P-G, Hauschke D. Effects of lung surfactant factor (LSF) treatment on gas exchange and Histopathological changes in an animal model of adult respiratory distress syndrome (ARDS). Comparison of recombinant LSF with bovine LSF. Pulm Pharmacol. 1995; 7 319-332
2 Häfner D, Germann P-G, Hauschke D. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in an animal model of the acute respiratory distress syndrome. Brit J Pharmacol. 1998; 124 1083-1090
3 Häfner D, Germann P-G, Hauschke D. ARDS model in the rat: Influence of early and late treatment with surfactant in an animal model of acute lung injury. Arzneimittelforsch. 1998; 48 (3) 318-320
4 Häfner D, Germann P-G, Hauschke D. Effects of rSP-C surfactant on oxygenation and histology in a rat lung lavage model of acute lung injury. Am J Respir Crit Care Med. 1998; 158 (1) 270-278
5 Germann P-G, Häfner D. A rat model of acute respiratory distress syndrome (ARDS): Part 1, time dependency of histological and pathological changes. J Pharmacol Toxicol Methods. 1998; 40 101-107
6 Häfner D, Germann P-G, Hauschke D. et al . Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury. Pulm Pharmacol Ther. 1999; 12 193-201
7 Vangerow B, Häfner D, Rueckoldt H. et al . Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury. Intensive Care Med. 2001; 27 1526-1531
8 Spragg R G, Smith R M, Harris K. et al . Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J Appl Physiol. 2000; 88 (2) 674-681
9 Häfner D, Germann P-G. Dexamethasone enhances the activity of rSP-C surfactant but not of Exosurf in a rat model of the acute respiratory distress syndrome. J Pharmacol Toxicol Methods. 1999; 42 39-48
10 Germann P-G, Häfner D. A rat model of acute respiratory distress syndrome (ARDS): Part 2, influence of lavage volume, lavage repetition and therapeutic treatment with r-SP-C surfactant. J Pharmacol Toxicol Methods. 1999; 41 97-106
11 Germann P-G, Kemkowski J, Hauschke D. et al . Intratracheally applied r-SP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model for acute lung hypersensitivity. Exp Toxic Pathol. 1999; 51 495-505
12 Häfner D, Germann P-G. Additive effects of phosphodiesterase 4 inhibition on effects of rSP-C surfactant. Am J Resp Crit Care Med. 2000; 161 1495-1500
13 Germann P-G. Das akute Atemnotsyndrom im Tiermodell unter Berücksichtigung verschiedener Therapieansätze. Tierärztliche Hochschule Hannover: Habilitationsschrift 2001
14 Häfner D, Ibrahim M, Wollin L. et al . Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model. ExpToxicol Pathol. 2003; 55 (1) 59-68
15 Germann P-G, Häfner D. Experimental approaches for the treatment of the acute respiratory distress syndrome in a rat lavage model. Rec Res Devel Resp Critical Care Med. 2001; 1 161-179